{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:16:08Z","timestamp":1787868968390,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"\n Objective:<\/jats:title>\n The objective of this umbrella review was to examine various pharmacologic interventions for their potential to reduce etomidate-induced myoclonus. A secondary objective was to compare the relative effectiveness of those medications in reducing the incidence of myoclonus when etomidate is utilized for the induction of general anesthesia.<\/jats:p>\n <\/jats:sec>\n \n Introduction:<\/jats:title>\n Etomidate is the drug of choice when inducing general anesthesia in hemodynamically unstable patients. However, its use is limited among the general surgical population due to its ability to cause adrenal suppression, vomiting, and myoclonus. Myoclonus can lead to damage of muscle fibers, myalgias, and patient discomfort, and can also be detrimental in patients with low cardiac reserve. Several systematic reviews have reported on the effectiveness of various intravenous medications in reducing mild, moderate, and severe myoclonus; however, a more thorough examination of their influence was lacking.<\/jats:p>\n <\/jats:sec>\n \n Inclusion criteria:<\/jats:title>\n This review included systematic reviews and meta-analyses of randomized controlled trials involving the use of pharmacologic interventions to reduce etomidate-induced myoclonus. Reviews in English and conducted after 1965 were considered for inclusion.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n A comprehensive search of 11 databases was conducted to identify published and unpublished reviews up to March 2022. Critical appraisal was conducted by 2 independent reviewers using the standardized JBI appraisal tool. Quantitative findings were summarized according to the dose, timing of administration, and relative risk using a data matrix, and were synthesized in tabular format with supporting narrative text. Results were organized by severity of myoclonus (overall, mild, moderate, and severe) and by type of intervention.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Eight systematic reviews were included in this umbrella review, which included 48 relevant studies, after removal of duplicates (3909 participants included in the primary studies). Five of the systematic reviews examined the effectiveness of various types of opioids in the prevention of myoclonus, and 3 systematic reviews examined the effectiveness of non-opioid interventions, such as lidocaine, midazolam, and dexmedetomidine. Seven reviews searched at least 4 databases for pertinent studies and specifically indicated that blinded reviewers appraised the articles. All reviews used a published and validated appraisal instrument. The overall quality of all included reviews was judged to be moderate to high. The absolute risk reduction indicating the effectiveness of the prophylactic medications ranged from 47% to 81% for mild, 52% to 92% for moderate, and 61% to 96% for severe myoclonus. Opioids demonstrated the most consistent and substantial effect on the reduction in myoclonus.<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n All pharmacologic interventions identified in this review demonstrated a statistically significant reduction in the incidence of myoclonus. Future studies and reviews should focus on elucidating the particular dose range and timing that is most effective. Anesthesia providers should consider a pre-treatment dose of one of the medications described in this umbrella review as a means to reduce myoclonus and the untoward effects of that condition.<\/jats:p>\n <\/jats:sec>","DOI":"10.11124\/jbies-22-00390","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T09:00:14Z","timestamp":1691658014000},"page":"66-89","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological interventions for reducing the incidence of myoclonus in patients receiving etomidate for induction of general anesthesia: an umbrella review"],"prefix":"10.11124","volume":"22","author":[{"given":"Jennifer","family":"Greenwood","sequence":"first","affiliation":[{"name":"Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA"},{"name":"RFU Center for Interprofessional Evidence Based Practice: A JBI Centre of Excellence, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Crull","sequence":"additional","affiliation":[{"name":"Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Graves","sequence":"additional","affiliation":[{"name":"Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ledvina","sequence":"additional","affiliation":[{"name":"Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1]]},"reference":[{"issue":"3","key":"R1-20250613","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/ALN.0b013e3181ff72b5","article-title":"Clinical and molecular pharmacology of etomidate","volume":"114","author":"Forman","year":"2011","journal-title":"Anesthesiol"},{"issue":"1","key":"R3-20250613","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/aer.AER_188_18","article-title":"Effect of fentanyl and nalbuphine for prevention of etomidate-induced myoclonus","volume":"13","author":"Bisht","year":"2019","journal-title":"Anesth Essays Res"},{"key":"R4-20250613","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2147\/DDDT.S200200","article-title":"Comparison of the efficacy and safety of remifentanil versus different pharmacological approaches on prevention of etomidate-induced myoclonus: a meta-analysis of randomized controlled trials","volume":"13","author":"Lang","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R5-20250613","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2147\/DDDT.S121979","article-title":"Effect of dexmedetomidine in preventing etomidate-induced myoclonus: a meta-analysis","volume":"11","author":"Du","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"R6-20250613","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0300060516682882","article-title":"Effect of pretreatment with midazolam on etomidate-induced myoclonus: a meta-analysis","volume":"45","author":"Zhou","year":"2017","journal-title":"J Int Med Res"},{"issue":"6","key":"R7-20250613","doi-asserted-by":"crossref","first-page":"e2701","DOI":"10.1097\/MD.0000000000002701","article-title":"Low-dose ketamine pretreatment reduces the incidence and severity of myoclonus induced by etomidate: a randomized, double-blinded, controlled clinical trial","volume":"95","author":"Guan-Nan","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"R8-20250613","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1097\/MJT.0000000000000404","article-title":"Efficacy and safety of opioids for the prevention of etomidate-induced myoclonus: a meta-analysis","volume":"25","author":"Wang","year":"2018","journal-title":"Am J Ther"},{"key":"R9-20250613","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.2147\/DDDT.S174057","article-title":"Pretreatment with lidocaine reduces both incidence and severity of etomidate-induced myoclonus: a meta-analysis of randomized controlled trials","volume":"12","author":"Lang","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"R11-20250613","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"R14-20250613","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"Aromataris","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"7650","key":"R15-20250613","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyat","year":"2008","journal-title":"BMJ"},{"key":"R16-20250613","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2147\/DDDT.S191982","article-title":"Effect of butorphanol on etomidate-induced myoclonus: a systematic review and meta-analysis","volume":"13","author":"Hua","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R17-20250613","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2147\/DDDT.S137464","article-title":"Using dezocine to prevent etomidate-inducted myoclonus: a meta-analysis of randomized trails","volume":"11","author":"Zhu","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"R18-20250613","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0300060518801457","article-title":"Butorphanol effectively prevents etomidate-induced myoclonus: a pooled analysis of 788 patients","volume":"47","author":"Zhu","year":"2019","journal-title":"J Int Med Res"},{"issue":"2","key":"R19-20250613","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jclinane.2005.05.004","article-title":"Remifentanil pretreatment reduces myoclonus after etomidate","volume":"18","author":"Kelsaka","year":"2006","journal-title":"J Clin Anesth"},{"issue":"1","key":"R20-20250613","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/147323000803600103","article-title":"A comparison of midazolam with remifentanil for the prevention of myoclonic movements following etomidate injection","volume":"36","author":"Hwang","year":"2008","journal-title":"J Int Med Res"},{"issue":"1","key":"R21-20250613","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00540-014-1854-2","article-title":"Dezocine pretreatment prevents myoclonus induced by etomidate: a randomized, double-blinded con- trolled trial","volume":"29","author":"He","year":"2015","journal-title":"J Anesth"},{"issue":"6","key":"R22-20250613","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00540-014-1886-7","article-title":"Intravenous dezocine pretreatment reduces the incidence and intensity of myoclonus induced by etomidate","volume":"28","author":"Lv","year":"2014","journal-title":"J Anesth"},{"key":"R23-20250613","first-page":"w14042","article-title":"Butorphanol prevents myoclonus induced by etomidate: a randomised, double-blind, controlled clinical trial","volume":"144","author":"He","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"R24-20250613","first-page":"1325","article-title":"Comparison of butorphanol or midazolam alone and combination of the two drugs in preventing etomidate-induced myoclonus during anesthesia induction","volume":"35","author":"Zhang","year":"2015","journal-title":"Chin J Anesthesiol"},{"key":"R25-20250613","first-page":"280","article-title":"Comparison of butorphanol or fentanyl in preventing etomidate-induced myoclonus during anesthesia induction","volume":"28","author":"Zhao","year":"2008","journal-title":"Chin J Anesthesiol"},{"key":"R26-20250613","first-page":"58","article-title":"The effect of butorphanol on myoclonus induced by etomidate","volume":"53","author":"Ren","year":"2013","journal-title":"Shandong Med J"},{"key":"R27-20250613","first-page":"1450","article-title":"Comparison of the effects of intravenous pre-treatment of butorphanol and dezocine on prevention of etomidate-induced myoclonus","volume":"43","author":"Jing","year":"2015","journal-title":"Tianjin Med J"},{"key":"R28-20250613","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0022-3565(24)37305-7","article-title":"Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology","volume":"284","author":"Bausch","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"R29-20250613","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bpa.2017.07.002","article-title":"Opioid-related side effects: postoperative ileus, urinary retention, nausea and vomiting, and shivering. A review of the literature","volume":"31","author":"de Boer","year":"2017","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"5","key":"R30-20250613","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1213\/ANE.0000000000002497","article-title":"A review of opioid-sparing modalities in perioperative pain management: methods to decrease opioid use postoperatively","volume":"125","author":"Kumar","year":"2017","journal-title":"Anesth Analg"},{"issue":"2","key":"R32-20250613","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/AIA.0b013e31828d58c7","article-title":"Perioperative uses of dexmedetomidine","volume":"51","author":"Jones","year":"2013","journal-title":"Int Anesthesiol Clin"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-22-00390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:33:55Z","timestamp":1786451635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-22-00390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.11124\/jbies-22-00390","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}